News & Views

ONS board of directors

ONS Board Wraps Up 2020 With Leadership Planning

In its year-end wrap-up meeting on December 8, 2020, the ONS Board of Directors focused on oncology nursing leadership development, both within the general nursing profession as well as within the Society itself. It also finalized the topics for the annual ONS membership survey for January 2021. Highlights from those conversations follow, and ONS members can read a full report in the meeting minutes.

February 08, 2021

Trending Topics

View All Topics

Nursing Considerations for Lymphoma Survivorship Care

Nursing Considerations for Lymphoma Survivorship Care

February 04, 2021

FDA Grants Accelerated Approval to Tepotinib for Metastatic NSCLC

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Tepotinib for Metastatic NSCLC

February 03, 2021

Even Short Treatment Delays Affect Cancer Outcomes

Even Short Treatment Delays Affect Cancer Outcomes

February 03, 2021

Cancer Support Groups Help Patients Develop Critical Connections

Patient Support

Cancer Support Groups Help Patients Develop Critical Connections

February 02, 2021

Social Isolation in Patients With Cancer

Patient empowerment

Being Apart Doesn’t Mean Fighting Cancer Alone

February 02, 2021

Leadership Is the Foundational Competency for Oncology Nursing in 2029

Leadership Is the Foundational Competency for Oncology Nursing in 2029

February 01, 2021

Nursing Considerations for Breast Cancer Survivorship Care

Nursing Considerations for Breast Cancer Survivorship Care

January 28, 2021

First-Time Smoking Age Increases Among Young Adults

First-Time Smoking Age Increases Among Young Adults

January 27, 2021

Oncology Drug Reference Sheet: Tafasitamab-Cxix

Oncology drug research

Oncology Drug Reference Sheet: Tafasitamab-Cxix

January 26, 2021

Meet Your ONS Leader: Darcy Burbage

Meet Your ONS Leader: Darcy Burbage

January 25, 2021

Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)

Genetics & genomics

Genetic Disorder Reference Sheet: Lynch Syndrome (Hereditary Nonpolyposis Colorectal Cancer)

January 25, 2021

FDA Approves Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma

Cancer treatments

FDA Approves Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma

January 25, 2021

How Can Innovation and Opportunity Guide a Career in Nursing Research?

How Can Innovation and Opportunity Guide a Career in Nursing Research?

January 20, 2021

The Case of the Targeted Therapy Toxicities

Clinical practice

The Case of the Targeted Therapy Toxicities

January 19, 2021

FDA Approves Fam-Trastuzumab Deruxtecan-Dxki for HER2-Positive Gastric Adenocarcinomas

Cancer treatments

FDA Approves Fam-Trastuzumab Deruxtecan-Dxki for HER2-Positive Gastric Adenocarcinomas

January 19, 2021

Lifelong Learning and Professional Development Are Crucial to Patient Outcomes

nursing professional development

Lifelong Learning and Professional Development Are Crucial to Patient Outcomes

January 18, 2021

What the Evidence Says for Guided Imagery in Oncologic Care

Complementary therapy

What the Evidence Says for Guided Imagery in Oncologic Care

January 18, 2021

$FDA Approves Crizotinib for Children and Young Adults With Relapsed or Refractory, Systemic ALK-Positive Anaplastic Large Cell Lymphoma$

Cancer treatments

FDA Approves Crizotinib for Children and Young Adults With Relapsed or Refractory, Systemic ALK-Positive Anaplastic Large Cell Lymphoma

January 15, 2021

Nurses Break Record as Most Trusted Profession for 19 Years Running

Oncology nursing community

Nurses Break Record as Most Trusted Profession for 19 Years Running

January 15, 2021

How to Accept Criticism With Class

Interprofessional issues

How to Accept Criticism With Class

January 14, 2021

Genomics Provides Insight on Exceptionally Responding Patients

Genetics & genomics

Genomics Provides Insight on Exceptionally Responding Patients

January 13, 2021

Manage Cancer Treatment-Related Radiodermatitis With ONS Guidelines™

Clinical practice guidelines

Manage Cancer Treatment-Related Radiodermatitis With ONS Guidelines™

January 12, 2021

ONS Enterprise Plans for the Future of Cancer Care

ONS Enterprise Plans for the Future of Cancer Care

January 11, 2021

How Does Nursing Certification Foster Lifelong Professional Development?

nursing professional development

How Does Nursing Certification Foster Lifelong Professional Development?

January 07, 2021

How COVID-19 May Increase Access to and Reduce Disparities in Cancer Clinical Trials

Cancer research

How COVID-19 May Increase Access to and Reduce Disparities in Cancer Clinical Trials

January 06, 2021

Sunstar Americas, Inc., Expands Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12%, for Microbial Contamination

U.S. Food and Drug Administration (FDA)

Sunstar Americas, Inc., Expands Voluntary Nationwide Recall of Paroex® Chlorhexidine Gluconate Oral Rinse USP, 0.12%, for Microbial Contamination

January 06, 2021

How Enhancing Your Career Benefits Both Your Patients and Yourself

nursing professional development

How Enhancing Your Career Benefits Both Your Patients and Yourself

January 05, 2021

Happy New Year’ Takes On New Meaning for 2021

'Happy New Year’ Takes On New Meaning for 2021

January 04, 2021

Adding Nivolumab to Chemo Improves Survival for Advanced Gastric Cancer

Adding Nivolumab to Chemo Improves Survival for Advanced Gastric Cancer

December 30, 2020

Oncology Drug Reference Sheet: Alpelisib

Clinical practice

Oncology Drug Reference Sheet: Alpelisib

December 29, 2020

Genomics May Trick PARP Inhibitors to Treat More Cancers

Genomics May Trick PARP Inhibitors to Treat More Cancers

December 23, 2020

Barbara Holmes Gobel

Meet Your ONS Leader: Barbara Holmes Gobel

December 22, 2020

FDA Approves Selinexor for Relapsed or Refectory Multiple Myeloma

U.S. Food and Drug Administration (FDA)

FDA Approves Selinexor for Relapsed or Refectory Multiple Myeloma

December 21, 2020

FDA Approves Osimertinib as Adjuvant Therapy for NSCLC With EGFR Mutations

U.S. Food and Drug Administration (FDA)

FDA Approves Osimertinib as Adjuvant Therapy for NSCLC With EGFR Mutations

December 21, 2020

FDA Approves Relugolix for Advanced Prostate Cancer

U.S. Food and Drug Administration (FDA)

FDA Approves Relugolix for Advanced Prostate Cancer

December 21, 2020

How to Establish a More Compassionate Workplace

Nurse well-being

How to Establish a More Compassionate Workplace

December 21, 2020

FDA Approves Margetuximab-cmkb for Metastatic HER2-Positive Breast Cancer

Cancer treatments

FDA Approves Margetuximab-cmkb for Metastatic HER2-Positive Breast Cancer

December 18, 2020

The Case of the Virtual Venture

Clinical practice

The Case of the Virtual Venture

December 17, 2020

What Is the Role of Genetic Counselors in Cancer Care?

Genetics & genomics

What Is the Role of Genetic Counselors in Cancer Care?

December 15, 2020

COVID-19 Reference Sheet: Vaccines

COVID-19 Reference Sheet: Vaccines

December 14, 2020

Generative Meetings Create a Foundation for Future Work

Generative Meetings Create a Foundation for Future Work

December 14, 2020

Telegenetic Counseling Bridges Geographic Barriers and Minimizes Distress

Telegenetic Counseling Bridges Geographic Barriers and Minimizes Distress

December 10, 2020

FDA Warns Against Wearing Face Masks With Metal During MRI Exams

U.S. Food and Drug Administration (FDA)

FDA Warns Against Wearing Face Masks With Metal During MRI Exams

December 10, 2020

Manage Cancer Treatment-Related Constipation With ONS Guidelines™

Clinical practice guidelines

Manage Cancer Treatment-Related Constipation With ONS Guidelines™

December 08, 2020

A New Year Offers Promise of Improvement

A New Year Offers Promise of Improvement

December 07, 2020

Pancreatic Cancer Risk Factors, Diagnosis, Treatment, Side Effects, and Survivorship Considerations

Pancreatic cancer

Pancreatic Cancer Risk Factors, Diagnosis, Treatment, Side Effects, and Survivorship Considerations

December 03, 2020

FDA Approves Pralsetinib for RET-Altered Thyroid Cancers

U.S. Food and Drug Administration (FDA)

FDA Approves Pralsetinib for RET-Altered Thyroid Cancers

December 02, 2020

NKT Cells May Be the Next Wave of CAR Therapy

NKT Cells May Be the Next Wave of CAR Therapy

December 02, 2020

Harnessing the Power of Genes

Genetics & genomics

Harnessing the Power of Genes

December 01, 2020

Back to Top ▲